Compile Data Set for Download or QSAR
maximum 50k data
Found 1086 with Last Name = 'raveglia' and Initial = 'l'
TargetDelta-type opioid receptor(MOUSE)
TBA

Curated by ChEMBL
LigandPNGBDBM50290872((-)-rel-3-((4aR,12aS)-2-methyl-1,2,3,4,4a,5,12,12a...)
Affinity DataKi:  0.230nMAssay Description:inhibition of [3H]DADLE binding to delta-opioid receptor of mouse brain homogenatesMore data for this Ligand-Target Pair
In DepthDetails Article
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604064(US11660293, Example 171 | US11660293, Example 173)
Affinity DataKi:  0.437nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDelta-type opioid receptor(MOUSE)
TBA

Curated by ChEMBL
LigandPNGBDBM50450528(CHEMBL2051964)
Affinity DataKi:  0.460nMAssay Description:inhibition of [3H]DADLE binding to delta-opioid receptor of mouse brain homogenatesMore data for this Ligand-Target Pair
In DepthDetails Article
TargetSubstance-K receptor(Rattus norvegicus (Rat))
Smithkline Beecham

Curated by ChEMBL
LigandPNGBDBM50291261((S)-(+)-N-((3-[1-Benzoyl-3-(3,4-dichlorophenyl)pip...)
Affinity DataKi:  0.510nMAssay Description:Ability to displace [125I]NKA from Tachykinin receptor 2 in rat deodenum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099628(3-[1,4']Bipiperidinyl-1'-ylmethyl-2-phenyl-quinoli...)
Affinity DataKi:  0.600nMAssay Description:Displacement of [125 I]-NKA binding to tachykinin receptor 2 in CHO membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
Via Zambeletti 25

Curated by ChEMBL
LigandPNGBDBM50208047(1-methyl-3-(2-oxo-4,4-diphenyl-imidazolidin-1-yl)-...)
Affinity DataKi:  0.670nMAssay Description:Displacement of [3H]N-methyl-scopalamine from human muscarinic M3 receptor expressed in CHOK1 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
Via Zambeletti 25

Curated by ChEMBL
LigandPNGBDBM50208057(1-methyl-3-(2-oxo-4,4-diphenyl-imidazolidin-1-yl)-...)
Affinity DataKi:  0.700nMAssay Description:Displacement of [3H]N-methyl-scopalamine from human muscarinic M3 receptor expressed in CHOK1 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099638(3-(4-Isopropyl-piperazin-1-ylmethyl)-2-phenyl-quin...)
Affinity DataKi:  0.700nMAssay Description:Displacement of [125 I]-NKA binding to tachykinin receptor 2 in CHO membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMuscarinic acetylcholine receptor M2(Homo sapiens (Human))
Via Zambeletti 25

Curated by ChEMBL
LigandPNGBDBM50208057(1-methyl-3-(2-oxo-4,4-diphenyl-imidazolidin-1-yl)-...)
Affinity DataKi:  0.730nMAssay Description:Displacement of [3H]N-methyl-scopalamine from human muscarinic M2 receptor expressed in CHOK1 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
Via Zambeletti 25

Curated by ChEMBL
LigandPNGBDBM50208043(1-methyl-3-(R)-[4,4-Bis-(4-fluoro-phenyl)-2-oxo-im...)
Affinity DataKi:  0.75nMAssay Description:Displacement of [3H]N-methyl-scopalamine from human muscarinic M3 receptor expressed in CHOK1 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM603987(US11660293, Example 61)
Affinity DataKi:  0.759nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099631(3-(4-Morpholin-4-yl-piperidin-1-ylmethyl)-2-phenyl...)
Affinity DataKi:  0.800nMAssay Description:Displacement of [125 I]-NKA binding to tachykinin receptor 2 in CHO membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuromedin-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099631(3-(4-Morpholin-4-yl-piperidin-1-ylmethyl)-2-phenyl...)
Affinity DataKi:  0.800nMAssay Description:Displacement of [125 I]-[MePhe]-NKB binding to hNK-3-CHO (Chinese hamster ovary) membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604048(US11660293, Example 152 | US11660293, Example 154)
Affinity DataKi:  0.871nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDelta-type opioid receptor(MOUSE)
TBA

Curated by ChEMBL
LigandPNGBDBM50061061((4aR,8aS)-6-Ethyl-8a-(3-hydroxy-phenyl)-3-methyl-4...)
Affinity DataKi:  0.950nMAssay Description:inhibition of [3H]DADLE binding to delta-opioid receptor of mouse brain homogenatesMore data for this Ligand-Target Pair
In DepthDetails Article
TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
Via Zambeletti 25

Curated by ChEMBL
LigandPNGBDBM50207996(3-(1-benzyl-azepin-4-yl)-5,5-diphenyl-imidazolidin...)
Affinity DataKi:  0.960nMAssay Description:Displacement of [3H]N-methyl-scopalamine from human muscarinic M3 receptor expressed in CHO K1 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuromedin-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50051293((S)-(-)-N-(R-ethylbenzyl)-3-hydroxy-2-phenylquinol...)
Affinity DataKi:  1nMAssay Description:Binding Affinity of [125I]-MePhe7-NKB towards Tachykinin receptor 3-CHO cell membranes(n=3-8)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099640(3-[1,4']Bipiperidinyl-1'-ylmethyl-2-phenyl-quinoli...)
Affinity DataKi:  1nMAssay Description:Displacement of [125 I]-NKA binding to tachykinin receptor 2 in CHO membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604115(US11660293, Example 234 | US11660293, Example 236)
Affinity DataKi:  1.02nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
Via Zambeletti 25

Curated by ChEMBL
LigandPNGBDBM50208044(1-methyl-3-(R)-(2-oxo-4,4-diphenyl-imidazolidin-1-...)
Affinity DataKi:  1.04nMAssay Description:Displacement of [3H]N-methyl-scopalamine from human muscarinic M3 receptor expressed in CHOK1 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604067(US11660293, Example 175 | US11660293, Example 177)
Affinity DataKi:  1.12nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604057(US11660293, Example 162 | US11660293, Example 164)
Affinity DataKi:  1.17nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099643(3-(4-Cyclohexyl-piperazin-1-ylmethyl)-2-phenyl-qui...)
Affinity DataKi:  1.20nMAssay Description:Displacement of [125 I]-[MePhe]-NKB binding to hNK-3-CHO (Chinese hamster ovary) membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuromedin-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50291261((S)-(+)-N-((3-[1-Benzoyl-3-(3,4-dichlorophenyl)pip...)
Affinity DataKi:  1.20nMAssay Description:Binding Affinity of [125I]-MePhe7-NKB towards Tachykinin receptor 3-CHO cell membranes(n=3-8)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099637(3-(4-Isobutyryl-piperazin-1-ylmethyl)-2-phenyl-qui...)
Affinity DataKi:  1.20nMAssay Description:Displacement of [125 I]-NKA binding to tachykinin receptor 2 in CHO membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuromedin-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50291261((S)-(+)-N-((3-[1-Benzoyl-3-(3,4-dichlorophenyl)pip...)
Affinity DataKi:  1.20nMAssay Description:Binding affinity towards cloned human Tachykinin receptor 3 (hNK-3) expressed in CHO cells using [125I][MePhe7]-NKBMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuromedin-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099632(3-(4-Isopropyl-piperazin-1-ylmethyl)-2-phenyl-quin...)
Affinity DataKi:  1.20nMAssay Description:Displacement of [125 I]-[MePhe]-NKB binding to hNK-3-CHO (Chinese hamster ovary) membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuromedin-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50074789(3-Amino-2-phenyl-quinoline-4-carboxylic acid ((R)-...)
Affinity DataKi:  1.20nMAssay Description:Binding affinity towards cloned human Tachykinin receptor 3 (hNK-3) expressed in CHO cells using [125I][MePhe7]-NKBMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604092(US11660293, Example 210 | US11660293, Example 211)
Affinity DataKi:  1.23nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604064(US11660293, Example 171 | US11660293, Example 173)
Affinity DataKi:  1.26nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM603991(US11660293, Example 89)
Affinity DataKi:  1.38nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604062(US11660293, Example 168 | US11660293, Example 170)
Affinity DataKi:  1.38nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50051293((S)-(-)-N-(R-ethylbenzyl)-3-hydroxy-2-phenylquinol...)
Affinity DataKi:  1.40nMAssay Description:Displacement of [125 I]-[MePhe]-NKB binding to hNK-3-CHO (Chinese hamster ovary) membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuromedin-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50074791(3-Hydroxy-2-phenyl-quinoline-4-carboxylic acid ((R...)
Affinity DataKi:  1.40nMAssay Description:Binding affinity towards cloned human Tachykinin receptor 3 (hNK-3) expressed in CHO cells using [125I][MePhe7]-NKBMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuromedin-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099637(3-(4-Isobutyryl-piperazin-1-ylmethyl)-2-phenyl-qui...)
Affinity DataKi:  1.40nMAssay Description:Displacement of [125 I]-[MePhe]-NKB binding to hNK-3-CHO (Chinese hamster ovary) membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604057(US11660293, Example 162 | US11660293, Example 164)
Affinity DataKi:  1.48nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099626(3-[1,4']Bipiperidinyl-1'-ylmethyl-2-phenyl-quinoli...)
Affinity DataKi:  1.5nMAssay Description:Displacement of [125 I]-[MePhe]-NKB binding to hNK-3-CHO (Chinese hamster ovary) membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(MOUSE)
TBA

Curated by ChEMBL
LigandPNGBDBM50290869((4aR,8aR)-7-Ethyl-4a-(3-hydroxy-phenyl)-3-methyl-4...)
Affinity DataKi:  1.5nMAssay Description:inhibition of [3H]DADLE binding to delta-opioid receptor of mouse brain homogenatesMore data for this Ligand-Target Pair
In DepthDetails Article
TargetNeuromedin-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50074785(3-(2-Hydroxy-ethoxy)-2-phenyl-quinoline-4-carboxyl...)
Affinity DataKi:  1.5nMAssay Description:Binding affinity towards cloned human Tachykinin receptor 3 (hNK-3) expressed in CHO cells using [125I][MePhe7]-NKBMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099632(3-(4-Isopropyl-piperazin-1-ylmethyl)-2-phenyl-quin...)
Affinity DataKi:  1.5nMAssay Description:Displacement of [125 I]-NKA binding to tachykinin receptor 2 in CHO membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604066(US11660293, Example 174)
Affinity DataKi:  1.51nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(GUINEA PIG)
Glaxosmithkline

Curated by PDSP Ki Database
LigandPNGBDBM85845(N-[(S)-1-Phenylpropyl]-2-phenyl-3-(carboxymethoxy)...)
Affinity DataKi:  1.60nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099643(3-(4-Cyclohexyl-piperazin-1-ylmethyl)-2-phenyl-qui...)
Affinity DataKi:  1.60nMAssay Description:Displacement of [125 I]-NKA binding to tachykinin receptor 2 in CHO membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
Via Zambeletti 25

Curated by ChEMBL
LigandPNGBDBM50208035(1-methyl-3-(R)-3-[4,4-bis-(4-fluoro-phenyl)-2-oxo-...)
Affinity DataKi:  1.62nMAssay Description:Displacement of [3H]N-methyl-scopalamine from human muscarinic M3 receptor expressed in CHOK1 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604069(US11660293, Example 178 | US11660293, Example 180)
Affinity DataKi:  1.66nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMuscarinic acetylcholine receptor M2(Homo sapiens (Human))
Via Zambeletti 25

Curated by ChEMBL
LigandPNGBDBM50208038(1-methyl-3-(2-oxo-4,4-diphenyl-imidazolidin-1-yl)-...)
Affinity DataKi:  1.66nMAssay Description:Displacement of [3H]N-methyl-scopalamine from human muscarinic M2 receptor expressed in CHOK1 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuromedin-K receptor(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099628(3-[1,4']Bipiperidinyl-1'-ylmethyl-2-phenyl-quinoli...)
Affinity DataKi:  1.70nMAssay Description:Displacement of [125 I]-[MePhe]-NKB binding to hNK-3-CHO (Chinese hamster ovary) membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
Via Zambeletti 25

Curated by ChEMBL
LigandPNGBDBM50208018(3-(1-(3-methylbenzyl)-piperidin-4-yl)-5,5-di-(2-th...)
Affinity DataKi:  1.72nMAssay Description:Displacement of [3H]N-methyl-scopalamine from human muscarinic M3 receptor expressed in CHO K1 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
Via Zambeletti 25

Curated by ChEMBL
LigandPNGBDBM50208056(1-methyl-3-(2-oxo-4,4-diphenyl-imidazolidin-1-yl)-...)
Affinity DataKi:  1.76nMAssay Description:Displacement of [3H]N-methyl-scopalamine from human muscarinic M3 receptor expressed in CHOK1 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604132(US11660293, Example 254 | US11660293, Example 256)
Affinity DataKi:  1.78nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 1086 total ) | Next | Last >>
Jump to: